Hong Kong bourse returns Aim Vaccine’s IPO application
myskin - stock.adobe.com
Hong Kong’s stock exchange has rejected an IPO application from Aim Vaccine, a leading Chinese vaccine maker. The deal is being sponsored by China Securities, CICC, Goldman Sachs and Macquarie.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: